Streptococcus iniae in aquaculture: a review of pathogenesis, virulence, and antibiotic resistance.
| Autor: | Juárez-Cortés MZ; Instituto Politécnico Nacional-CICIMAR, Av. Instituto Politécnico Nacional S/N, La Paz, México., Vázquez LEC; CONAHCYT- Universidad de Guanajuato. Food Department, Life Science Division, University of Guanajuato Campus Irapuato-Salamanca. Irapuato, Guanajuato, México., Díaz SFM; Instituto Politécnico Nacional-CICIMAR, Av. Instituto Politécnico Nacional S/N, La Paz, México., Cardona Félix CS; CONAHCYT- Instituto Politécnico Nacional-CICIMAR, Av. Instituto Politécnico Nacional S/N, México. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | International journal of veterinary science and medicine [Int J Vet Sci Med] 2024 May 13; Vol. 12 (1), pp. 25-38. Date of Electronic Publication: 2024 May 13 (Print Publication: 2024). |
| DOI: | 10.1080/23144599.2024.2348408 |
| Abstrakt: | One of the main challenges in aquaculture is pathogenic bacterial control. Streptococcus iniae stands out for its ability to cause high mortality rates in populations of commercially important fish populations and its recent recognition as an emerging zoonotic pathogen. The rise in identifying over 80 strains some displaying antibiotic resistance coupled with the emerging occurrence of infections in marine mammal species and wild fish underscores the urgent need of understanding pathogenesis, virulence and drug resistance mechanisms of this bacterium. This understanding is crucial to ensure effective control strategies. In this context, the present review conducts a bibliometric analysis to examine research trends related to S. iniae , extending into the mechanisms of infection, virulence, drug resistance and control strategies, whose relevance is highlighted on vaccines and probiotics to strengthen the host immune system. Despite the advances in this field, the need for developing more efficient identification methods is evident, since they constitute the basis for accurate diagnosis and treatment. Competing Interests: No potential conflict of interest was reported by the author(s). (© 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|